Hot Pursuit     21-May-24
Zydus Lifesciences Ltd soars 1.23%, gains for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 1117.55, up 1.23% on the day as on 12:44 IST on the NSE. The stock is up 120.75% in last one year as compared to a 23.15% jump in NIFTY and a 56.45% jump in the Nifty Pharma.

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at Rs 1117.55, up 1.23% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.23% on the day, quoting at 22553.55. The Sensex is at 74076.92, up 0.1%. Zydus Lifesciences Ltd has gained around 16.45% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 2.75% in last one month and is currently quoting at 19108, up 0.25% on the day. The volume in the stock stood at 32.38 lakh shares today, compared to the daily average of 15.73 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1119.05, up 1.08% on the day. Zydus Lifesciences Ltd is up 120.75% in last one year as compared to a 23.15% jump in NIFTY and a 56.45% jump in the Nifty Pharma index.

The PE of the stock is 41.35 based on TTM earnings ending December 23.

Previous News
  Zydus Life gets tentative USFDA nod for hypertension drugs
 ( Hot Pursuit - 14-Jun-24   12:34 )
  Zydus Lifesciences gets USFDA nod for ZITUVIO
 ( Hot Pursuit - 23-Oct-23   09:09 )
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
 ( Hot Pursuit - 08-Jul-24   13:01 )
  Zydus Lifesciences receives USFDA approval for Dapsone Gel 7.5%
 ( Corporate News - 09-May-24   12:36 )
  Zydus announces NDA acceptance of Desidustat in China by NMPA
 ( Corporate News - 23-Apr-24   16:06 )
  Zydus Lifesciences gains as board mulls share buyback
 ( Hot Pursuit - 06-Feb-24   09:33 )
  Zydus Lifesciences consolidated net profit rises 109.70% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   17:49 )
  Zydus enters into licensing and supply agreement with MSN Laboaratories
 ( Corporate News - 17-May-24   09:07 )
  Zydus Lifesciences receives USFDA approval for Isosorbide Mononitrate ER Tablets
 ( Corporate News - 16-Feb-24   14:31 )
  Zydus receives USFDA approval for Esomeprazole Magnesium for Delayed-Release Oral Suspension
 ( Corporate News - 08-Jun-23   14:43 )
  Zydus Life gets USFDA nod for Sugammadex injection
 ( Hot Pursuit - 06-Oct-23   14:57 )
Other Stories
  Wipro Q1 PAT rises 6% QoQ to Rs 3,003 cr
  19-Jul-24   17:22
  BPCL tanks after Q1 PAT slides 71% YoY to Rs 3,015 cr in FY25
  19-Jul-24   15:45
  Fedbank Financial Services Q1 PAT rises 4% YoY to Rs 70 cr
  19-Jul-24   15:33
  UltraTech Cement Q1 PAT rises YoY to Rs 1,697 crore
  19-Jul-24   15:32
  Jubilant Pharmova hits 52-week high after Q1 PAT zooms to Rs 482 cr
  19-Jul-24   15:06
  Chennai Petroleum Corporation Ltd leads losers in 'A' group
  19-Jul-24   15:00
  Nakoda Group of Industries Ltd Partly Paidup leads losers in 'B' group
  19-Jul-24   14:45
  Volumes spurt at AIA Engineering Ltd counter
  19-Jul-24   14:30
  Metal stocks edge lower
  19-Jul-24   14:00
  Real Estate stocks edge lower
  19-Jul-24   14:00
Back Top